LON:LID - LiDCO Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 4.60 0.00 (0.00 %) (As of 04/21/2019 04:00 PM ET)Previous CloseGBX 4.60Today's RangeGBX 4.60 - GBX 4.6052-Week RangeGBX 3.29 - GBX 8.25VolumeN/AAverage Volume183,119 shsMarket Capitalization£11.23 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides a range of closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor. It also offers LiDCOunity, a hemodynamic monitor to support clinical decision making; and LiDCOrapid, a cardiac output monitor that analyses the blood pressure waveform to provide information in surgical and critically ill patients to help with fluid and drug management. In addition, the company offers LiDCOplus, a hemodynamic monitor, which provides assessment of the hemodynamic status of critical care and surgery patients; LiDCOview that offers clinical researchers and users with beat-to-beat hemodynamic data; and accessories, including blood pressure modules. LiDCO Group Plc was founded in 1991 and is headquartered in London, the United Kingdom. Receive LID News and Ratings via Email Sign-up to receive the latest news and ratings for LID and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Medical Appliances & Equipment Sub-IndustryN/A SectorMedical Current SymbolLON:LID Previous Symbol CUSIPN/A CIKN/A Webwww.lidco.com Phone+44-20-77491500Debt Debt-to-Equity RatioN/A Current Ratio2.58 Quick Ratio1.66Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£7.32 million Price / Sales1.53 Cash FlowGBX 0.70 per share Price / Cash Flow6.57 Book ValueGBX 2.70 per share Price / Book1.70Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees48 Outstanding Shares244,175,008Market Cap£11.23 million Next Earnings DateN/A OptionableNot Optionable LiDCO Group (LON:LID) Frequently Asked Questions What is LiDCO Group's stock symbol? LiDCO Group trades on the London Stock Exchange (LON) under the ticker symbol "LID." Has LiDCO Group been receiving favorable news coverage? Media headlines about LID stock have trended neutral recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. LiDCO Group earned a news sentiment score of 0.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. Who are some of LiDCO Group's key competitors? Some companies that are related to LiDCO Group include Intelligent Ultrasound Group (MED), Zecotek Photonics (ZMS), Deltex Medical Group (DEMG), InspireMD (NSPR), Bioquell (BQE), Lucid (LCDX) and Verisante Technology (VRS). What other stocks do shareholders of LiDCO Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other LiDCO Group investors own include African Potash (AFPO), Satellite Solutions Worldwide (SAT), El Pollo LoCo (LOCO), Biopharma Credit (BPCR), Best of the Best (BOTB), Destiny Pharma (DEST), DX (Group) (DX), Fulcrum Utility Services (FCRM), Poundland Group (PLND) and Templeton Emerging Markets Inv Trust (TEM). Who are LiDCO Group's key executives? LiDCO Group's management team includes the folowing people: Mr. Matthew G. Sassone, CEO & DirectorDr. Terence K. O'Brien, Co-Founder & Member of Clinical Advisory Board (Age 64)Dr. David M. Band, Co-FounderMr. Tim R. Hall, CFO, Company Sec. & Director (Age 56)Mr. Shane Doorish, Head of North America How do I buy shares of LiDCO Group? Shares of LID and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is LiDCO Group's stock price today? One share of LID stock can currently be purchased for approximately GBX 4.60. How big of a company is LiDCO Group? LiDCO Group has a market capitalization of £11.23 million and generates £7.32 million in revenue each year. LiDCO Group employs 48 workers across the globe. What is LiDCO Group's official website? The official website for LiDCO Group is http://www.lidco.com. How can I contact LiDCO Group? LiDCO Group's mailing address is 16 Orsman Road, LONDON, N1 5QJ, United Kingdom. The company can be reached via phone at +44-20-77491500. MarketBeat Community Rating for LiDCO Group (LON LID)Community Ranking: 1.9 out of 5 ()Outperform Votes: 155 (Vote Outperform)Underperform Votes: 247 (Vote Underperform)Total Votes: 402MarketBeat's community ratings are surveys of what our community members think about LiDCO Group and other stocks. Vote "Outperform" if you believe LID will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LID will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/21/2019 by MarketBeat.com StaffFeatured Article: How accurate is the Rule of 72?